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Abstract 7 
Ganoderma lucidum BCCM 31549 has a long established role for its therapeutic activities. In this 8 
context, much interest has focused on the possible functions of the (1,3)-ȕ-D-glucan (G) 9 
produced by these cultures in a stirred-tank bioreactor and extracted from their underutilized 10 
mycelium. In the existing study, we report on the systematic production of G, and its sulfated 11 
derivative (GS). The aim of this study was to investigate the G and its GS from G. lucidum in 12 
terms of antibacterial properties, and cytotoxicity spectrum against Human-Prostate-Cell 13 
(PN2TA) and Human-Caucasian-Histiocytic-Lymphoma (U937). 1H NMR for both G and GS 14 
FRPSRXQGVVKRZHGȕ-glycosidic linkages and structural similarities when compared with two 15 
standards (Laminarin and Fucoidan). The existence of characteristic absorptions at 1,170 and 867 16 
cm-1 in the FTIR for GS demonstrated the successful sulfation of G. Only GS exhibited 17 
antimicrobial activity against a varied range of test bacteria of relevance to foodstuffs and human 18 
health. Moreover, both G and GS did not show any cytotoxic effects on PN2TA cells, thus 19 
helping demonstrate the safety on these polymers. Also, GS shows 40% antiproliferation against 20 
cancerous U937 cells at low concentration (60 µg/mL) applied in this study compared to G 21 
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(10%). Together, this demonstrates that sulfation clearly improved the solubility and therapeutic 22 
activities of G. The water-soluble GS demonstrates the potential multi-functional effects of these 23 
materials in foodstuffs. 24 
Keywords 25 
Ganoderma lucidum, (1,3)-ȕ-D-glucan sulfate, Antimicrobial activity, Cytotoxicity 26 
Running title: Antimicrobial activity of G. lucidum glucan sulfate 27 
1. INTRODUCTION 28 
Bacterial infection is one of the most significant causes of food degradation, and there is 29 
little attention on the role of food producers to prevent this phenomenon. Foodstuffs represent a 30 
rich source of nutrients often stored under conditions of permissible temperature and humidity. In 31 
addition to food degradation by microorganisms, high levels of multiplying microorganisms 32 
present in the food may initiate food poisoning which can contribute to public health problems 33 
[1] and disrupting supply chain issues worldwide. Ideally, improving the safety and spoilage 34 
characteristics of foodstuffs by including other naturally occurring products which may possess 35 
both antimicrobial, and other desirable biological activities (e.g. cytotoxicity on cancer cells, 36 
health-giving), potentially offers a route to safer foods with enhanced health-imparting 37 
characteristics. This approach makes use of the potential for µ¶ELIXQFWLRQDO¶¶HIIHFWs [24] of 38 
glucan materials derived from traditional food sources, including some species of mushrooms 39 
[21]. These natural foods have been shown to be a relatively unexplored source for improvements 40 
in food safety, preservation while providing extra health benefits [40]. 41 
Mushrooms of the genus Ganoderma, have been eaten for many centuries in Asia to 42 
encourage well-being, durability and endurance [11, 22]. To date, more than 120 species of 43 
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Ganoderma have been identified across the world. In the last 30 years, there has been significant 44 
scientific interest in the species Ganoderma lucidum. This fungus has been lately shown to 45 
possesses varied health benefits, such as anti-bacterial effects [14] and antiproliferative effects on 46 
cancer cells [19]. In this study, ȕ-glucan produced by the cultures with potential bioactivities are 47 
extracted from the mycelia. 48 
The extracted mycelial G. lucidum ȕ-glucan (G) is known to act as biological response 49 
modifier. Therefore, much research has focused on this fungal polysaccharide as a functional 50 
foodstuff and source for the development of biomedical drugs [14].  The clinical utilizatioQRIȕ-51 
glucans has one main difficulty in addition to the limited availability referred to above, that is, 52 
their comparative absence of solubility in aqueous solution, which leads to difficulties in product 53 
analysis, formulation and delivery. This is usually ascribed to the high number of ±OH groups in 54 
the ȕ-glucan leading to the native polymer adopting a compact triple stranded helix conformation, 55 
which determines their poor solubility in aqueous condition [36]. These demonstrate the failure 56 
of existing glucan products and the proposed glucan sulfate would not. 57 
Upon preliminary isolation from G. lucidumWKHȕ-glucan mainly, (1-3)-ȕ-D-glucan exists 58 
as an insoluble microparticulate. Thus, a technique such as sulfation is needed to alter the 59 
PROHFXOH¶V hydrophobicity thus making it water-soluble and potentially more bioactive in 60 
aqueous systems. The proposed sulfation technique has been used as an effective approach to 61 
improve the antibacterial, antiproliferative, anti-inflammatory, antitumor, and 62 
immunomodulatory activity of a range other polysaccharides [5, 17, 38, 40]. A previous effort by 63 
Williams et al.,[37] demonstrated that insoluble (1-3)-ȕ-glucan was able to dissolve in water by a 64 
sulfation process, while increasing the positive biological functions [5]. 65 
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To date, the cytotoxicity and antimicrobial activity of extracts from G. lucidum mycelia 66 
particularly the glucan sulfate (GS) have not been completely characterized. In the current study, 67 
glucan from G. lucidum mycelia was sulfated. Both glucan (G) and sulfated glucan (GS) 68 
structures were matched to known standards and screened antimicrobial and cytotoxic effects. 69 
The results showed that GS exhibited significant antimicrobial activities as well as 70 
antiproliferative responses while showing no toxic effects and hence could be utilized as a 71 
potential additive in food systems. With that, LW¶V presence would inhibit both spoilage and 72 
pathogenic bacteria, and impart significant health benefits noted in this study. 73 
2. MATERIALS AND METHODS 74 
2.1 Reagents 75 
Gentamicin susceptibility test discs (30 µg of concentration) were supplied by Thermo 76 
Scientific Oxoid (Fisher Scientific, Loughborough, UK). In this experiment, (U937) Human-77 
Caucasian-Histiocytic-Lymphoma and Human-Prostate-Normal cell (PNT2A) were obtained 78 
from ECAAC, European Collection of Cell Cultures, supplied by (Sigma-Aldrich, Dorset, UK). 79 
DMEM and TrypLE([SUHVVwere provided by Gibco (Life Technologies, Paisley, UK). RPMI 80 
- Bio Whittaker® without L-glutamine was supplied by Lonza, Vergiers, Belgium. HBBS ±81 
+DQN¶VEDODQFHGVDOWVROXWLon was provided by Sigma-Aldrich, St. Louis, USA. The 96-wells 82 
plate, TPP 92096 was provided by TPP, Trasadingen, Switzerland. Cell culture spectroscopy 83 
analysis was done using Wallac9LFWRUH20 Multilabel Counter with IR, high-density TR-84 
Fluorometry, robot loading and stacker (PerkinElmer, Waltham, MA, USA). Entire solvents and 85 
chemicals were analytical grades. 86 
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2.2 Fungal material 87 
  G. lucidum BCCM 31549 was obtained from the Belgian Coordinated Collections of 88 
Microorganisms (BCCM/MUCL), [Agro] Industrial Fungi and Yeast Collection (Leuven, 89 
Belgium). The fungus was subcultured onto potato dextrose agar (PDA, Oxoid Limited, 90 
Hampshire, UK) upon receipt from the supplier to avoid any contamination and ensure viability 91 
as suggested from previous research [10]. Plates were inoculated and incubated at 30 oC for seven 92 
days and stored at 4 oC. The strain was preserved on PDA slants. The fermentation strategy was 93 
implemented in a stirred-tank bioreactor, and the mycelial pellets were extracted. 94 
2.3 Extraction, isolation, and sulfation 95 
  Distilled water (D2O) was functioned to rinse the mycelium (biomass) off the sieves from 96 
the fermented culture broth. Through Whatman filter paper; they were filtered and vaporized to 97 
50 mL at 60-80 oC. This volume was added to 150 mL of ethanol, for macromolecules 98 
precipitation, containing the desired polysaccharide-GHULYHGȕ-glucan. A glass rod was used to 99 
obtained the product by twirling. Based on the macromolecules precipitation, the precipitate was 100 
attached or adsorbed onto the glass rod and harvested from the solution. The glucose, however, 101 
may be confined within the extracted precipitate, which was then splashed using 96% (v/v) 102 
ethanol. Subsequently, the solution was dialyzed against distilled water for three days (MW cut-103 
off = 10,000 Da) using a dialysis tube (Fisher Scientific, Loughborough, UK). The residual 104 
glucan was aerated and pre-chill in -20 oC freezer. After a couple of hours (h), the samples were 105 
transferred to -80 oC freezer for 24 h and then freeze-dried for 48 h. Later on, the build-up 106 
moisture surrounding the precipitated glucan were completely evaporated. It was then re-107 
suspended in distilled water, freeze-dried in -80 oC freezer and evaluated to yield a 1,3-ȕ-D-108 
glucan (G).  109 
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The G produced from the bioreactor fermentation processes was water-insoluble; 110 
therefore an inevitable process needs to be implemented to increase its solubility in water. Suzuki 111 
et al., [32] and Williams et al., [37] did sulfation of active 1,3-ȕ-D-glucans to increase their 112 
solubility or increase their bioavailability. Hence, sulfation of the current water-insoluble G was 113 
executed in this experiment. The improvised method of G sulfation of Williams et al., [37] was 114 
followed. Soluble 1,3-ȕ-D-glucan sulphate (GS) was produced as outlined in Fig. 1. Firstly, 1 g 115 
of microparticulate G was liquefied in 50 mL of dimethyl sulfoxide (DMSO) containing 6 M 116 
urea. 8 mL of concentrated sulphuric acid was added drop-wise directly erstwhile to heating. In a 117 
water bath, the solution was heated at 100 oC, and the reaction process continued for 3 to 6 h. By 118 
90 minutes, a crystalline precipitate (ammonium sulfate) was formed. The mixture solution was 119 
then vented at room temperature, and 1 L of ultrapure, pyrogen-free, D2O (Millipore, Bedford, 120 
MA) was added. The GS solution was then pre-filtered to remove unreacted polymer in G. The 121 
GS solution was dialyzed using a Vivaflow 200, using a 10,000 MW cut-out filter (Sartorius 122 
Stedim Lab Ltd, Binbrook, UK). The final volume was reduced to 500 mL and lyophilized to 123 
dryness. 124 
2.4 Elemental analysis 125 
The content of C, H, O, N, and S were estimated using a Perkin Palmer 2400 Series II 126 
CHNS/O Elemental Analysis (Waltham, MA, USA) device. According to the recorded results of 127 
the elemental analysis, the degree of sulfation (DS) is defined by the following equation (A) 128 
according to Wang et al., [36]. 129 
 DS ൌ ଻ଶ௦ଷଶ௖                            (A) 130 
 7 
 
Where s is the mass ratio of S element in the product glucan sulfate (GS). From now on, DS 131 
signifies the number of sulfate groups per glucose residue. 132 
2.5 Infrared Spectroscopy  133 
FTIR spectra of the G and GS samples were taken using a FTIR 3000 spectrophotometer, 134 
(Jusco, Japan) following the method of Shi  [29]. For jelly-like specimens (GS), FTIR Attenuated 135 
Total Reflectance (ATR) [Perkin Elmer, USA] was used to acquire the spectrum. 136 
2.6 1H NMR Spectroscopy  137 
The NMR spectra of both G and GS were taken using a DXM 500 FT-NMR spectrometer 138 
(Bruker, Switzerland).  Both compounds were liquefied in deuterium oxide ±d6 at the 139 
concentration of about 10 mg/mL to 30 mg/mL. All spectra were carried out at 80 oC, 140 
respectively.  Scan number was 16, and the chemical shifts (į) indicated in parts per million 141 
(ppm). Laminarin from Laminaria digitata (Sigma-Aldrich, Dorset, UK) was used as the 142 
comparison standard for G while Fucoidan originated from Fucus vesiculosus (Sigma-Aldrich, 143 
Dorset, UK) was used as the comparison standard for GS. 144 
2.7 Bioassay of antimicrobial activity 145 
The test bacteria used for antimicrobial sensitivity testing comprise the bacteria 146 
Pseudomonas aeruginosa, Salmonella enteritidis, Staphylococcus aureus, Staphylococcus 147 
epidermis, Escherichia coli that were obtained from the General Microbiology Lab Collections 148 
SIPBS, Glasgow, UK. In addition, Escherichia coli EPIC S17, Salmonella BA54 SL1344 pSsaG, 149 
Listeria monocytogenes, Shigella sonnei 20071599, and Methicillin-Susceptible-Staphylococcus 150 
aureus (MSSA) ATCC 292123 were kindly supplied by Dr. Jun Yu, SIPBS, Glasgow, UK. At 20 151 
oC, the strains were kept in the suitable freshly-prepared medium and rejuvenated two times 152 
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before being applied in the proposed assays. Bacteria were cultured with the oxygen supplied 153 
environment at 37 oC (Incubator- Bruker 200, Thermo, UK) in nutrient agar (NA) medium for 154 
bacteria. 155 
2.7.1 Kirby-Bauer disk diffusion assay, MIC, and MBC 156 
  Determination of antimicrobial activity was carried out using the Kirby-Bauer disk 157 
diffusion assay method. First, 20 mL of NA medium were decanted into each Petri dish. All test 158 
microorganisms were adjusted to 0.5 McFarland standards using sterile broth medium. Once 159 
hardened, about roughly 200 µL of suspension of the test bacteria was smeared on the prepared 160 
agar. The standardized 11 mm sterile discs (blank) (Sigma-Aldrich, Dorset, UK) with an identical 161 
absorbed GS volume were soaked with a known amount of extract. It was positioned moderately 162 
onto the agar overlay. The plates were carefully incubated overnight at 37 oC or 48 h or 30 oC for 163 
two days depending on the growth requirement of the bacterium. Gentamicin was applied as the 164 
positive control while ethanol was the negative control. After the incubation, the diameters (mm) 165 
of the inhibition zone were measured. Inhibition zones that were higher than 11 mm were 166 
considered positive for antimicrobial reactions. 167 
The minimal inhibitory concentration (MIC) was evaluated by microdilution using 96-168 
well microtitre plates according to Li et al., [20] with slight modifications. Sterile broth medium 169 
in conjunction with 0.5 McFarland standards was used as bacterial suspensions adjustment. GS 170 
compounds were dissolved in sterile ultrapure water and serially diluted into (mg/mL) 200, 100, 171 
20, 10, 8, 5, 3, 2 and 1. The final mixture was 25 µL of compounds with 75 µL of a suspension of 172 
each bacterium (working volume of 100 µL). Each test culture was pipetted onto the plates and 173 
incubated for 24 h at 30 oC. Once the incubation time ended, the turbidity or cloudiness was 174 
taken as the signal or indication for bacterial growth. The lowest diluted concentration at which 175 
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the incubated mixture persisted clear after microscopic assessment (at the binocular microscope) 176 
was thus selected as the MICs. 177 
Based on the MIC observation, the level at which the incubated mixture stayed clear after 178 
the microscopic estimation was selected as the MIC. The microscopic growth range were then 179 
pipetted (100 µL) to the NA. Sterile L-spreaders were used to make the spreading even. 180 
Following that, the concentration indicating the MIC and at least two of the more concentrated 181 
dilutions were plated and enumerated to determine viable colonies specifically for minimum 182 
bactericidal concentration (MBC) determination. The media were cultured at 30 oC for 24 h to 183 
observe for any microorganism growth. For the MBC, the minimum or lowest concentration in 184 
the medium that had less than five colonies was used. 185 
The method by SIDR (Strathclyde Institute of Drug Research) was used for the 186 
antimicrobial test on the bacteria included Klebsiella pneumoniae ATCC 13883 and 187 
Mycobacterium marinum ATCC BAA 535 using the 96-well microtitre plates [4, 18]. These tests 188 
were in triplicate, and the GS was supplied at 10 mg/mL. Gentamicin was used as a positive 189 
control for the bacteria, and DMSO as the negative one. 190 
2.8 Bioassay of cytotoxicity  191 
2.8.1 On normal cells 192 
Cell lines were grown in the appropriate freshly-prepared complete medium in a cell 193 
culture incubator (gaseous composition 95% air, 5% CO2) at 37 oC. The PN2TA normal human 194 
prostate cell line was sustained in a complete medium comprising RPMI, penicillin-streptomycin 195 
(5 mL), 50 mL fetal bovine serum (FBS), L-glutamine (5 mL), and pH at 7.4. AlamarBlue® 196 
assay determined the cytotoxic effect of both G and GS. Initially, 96-well microtitre plates were 197 
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seeded with the PN2TA cells at 2 x 104 cells/mL for each well. Cells were permitted to cultivate 198 
one day afore being introduced to GS: 500, 300, 50, 30, 5, and 3 µg/mL. For the negative control 199 
group, 4% (v/v) of Triton-X was added to the medium. After the incubation for the indicated 200 
hours, 10% (working volume per well) of alamarBlue® reagent was decanted to each well and 201 
incubated for an extra 6 h in a humidified incubator. Once 6 h of incubation completed, the 202 
resazurin in the alamarBlue® undergoes oxidation-reduction change in response to cellular 203 
metabolic change. The reduced form resazurin is pink and extremely fluorescent, and the strength 204 
of fluorescence produced is proportional to some living cells undergone respiration. The 205 
wavelength of 570 nm was used for absorbance reading. For analysis, cytotoxic activity was 206 
calculated based on cell survival ratio (%). 207 
2.8.2 On cancer cells 208 
The cytotoxicity of both G and GS were also tested on the cancerous cell U937 by 96-209 
well microtitre plate using alamarBlue® assay. The U937 cells at a density of 3 x 105 cells/well 210 
were being exposed to 60, 50, 30, and 10 µg/mL of both G and GS at day one prior incubation. 211 
As for the control group, an identical volume of complete sterile medium was applied (positive 212 
control) while Triton X (4%) as the negative control. After incubation for the designated period, 213 
10% of alamarBlue® reagent was pipetted to each well and incubated for an extra 6 h in a 214 
humidified incubator. Following 6 h incubation, the alamarBlue® reagent initiated resazurin to 215 
undergoes oxidation-reduction change in response to the cellular metabolic modification. The 216 
wavelength of 570 nm was used for absorbance reading. For analysis, cytotoxic activity was 217 
calculated based on cell survival ratio (%). 218 
 219 
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2.9 Statistical analysis 220 
 221 
All analysis were carried out in triplicate, and the respective mean ± S.D determined 222 
using the software, GraphPad Prism 5 (Version 5.01) and shown as error bars. If the error bars do 223 
not appear then, they are less than the size of the icon or symbol. 224 
3. RESULTS AND DISCUSSION 225 
3.1 Glucan solubility 226 
 227 
  In this study, the method for solubilization of G employs DMSO to dissolve initially the 228 
water-insoluble G preceding sulfation [11]. The DMSO and other reaction products were 229 
removed from G by extensive dialysis to ensure the purity of the GS produced. The solubility of 230 
the GS in water was measured post-sulfation to assess the effects of sulfation on G. In ultrapure 231 
distilled water, the final solubility of G was below 5% (w/v), but that of its GS was above 95% 232 
(w/v). Table 1 recaps the solubility and yields of the insoluble G and soluble GS. Furthermore, 233 
the GS was readily dissolved without heating while the G needs 0.1 M of NaOH at 80 oC to assist 234 
dilution in water. The improved tractability of GS about G represents a significant aid in 235 
developing and implementing assays.  236 
The introduction of sulfate group has several purposes. %DVHGRQWKHSUHVHQWVWXG\¶V237 
findings, the aqueous solubility of the extracted G from the fermenter was as poor as that of G 238 
prepared from other procedures. Astonishingly, this was mentioned in the literature that G was 239 
less suitable for medicinal applications [13]. In terms of the commercial importance of bioactive 240 
glucan, the water insoluble G show slight bioactivity, although G by-products such as pullulan 241 
sulfate, lentinan sulfate, and dextran sulfate have been suggested to display high anti-HIV 242 
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activities and small anticoagulant activities [36]. Wang and Zhang [6] also revealed that the 243 
sulfation process on the fruiting bodies of G. lucidum producing G have led to enhanced 244 
antitumor and antiviral activities [23, 27]. However, comparable studies on the antimicrobial and 245 
cytotoxicity of mycelial-sourced GS are limited.  246 
3.2 Compositional analysis 247 
3.2.1 Elemental analysis 248 
Elemental analysis was accomplished to attain the composition of the GS and, therefore, 249 
its degree of sulfation (DS). Basic examination of lyophilized GS gives a composition of (w/w): 250 
24.5% C, 5.72% H, 49.92% O, 9.85% S, and 10.01% N (Table 2). When compared with standard 251 
fucoidan, GS had the same C and H values but slight different in H, O, and S. This was due to 252 
different sulfation technique applied on each GS and fucoidan, respectively, and this might 253 
generate different molecular weight.  254 
Based on the composition of GS, the DS of GS is thus 0.90 indicating 90 sulfate groups 255 
are present on every 100 glucose subunits within the polysaccharide on average. When compared 256 
with the previous DS value (0.94) of sulfated polysaccharide (S-GL) of G. lucidum reported by 257 
Wang and Zhang [34], the current DS value of GS (0.90) was broadly similar to each other. 258 
3.2.2 IR spectroscopy 259 
Table 3 and Fig. 2, summarize the results of using FTIR spectroscopy to assess the 260 
structural characteristics of the G and GS. Both molecules showed the typical IR absorptions of 261 
polysaccharides at 1,250 and 1,650 cm-1: 1,170 and 1,651 cm-1, respectively. These IR 262 
absorptions as well as those LQWKHµDQRPHULFUHJLRQ¶DW± 700 cm-1 allow us to GLIIHUHQWLDWHȕ263 
IURPĮ glucans spectroscopically [35]. Overall, the D-glucosLGLFOLQNDJHDUUDQJHPHQWLVȕ-type 264 
both prior to and the following sulfation. 265 
 13 
 
 In the functional group region of the G-spectra, there were significant absorptions at 266 
3,400, 1,077, 2,925, 1,374, 1,647 , 1,246, 1,540, 1,077, and 892 cm-1, which resembles the 267 
elongating absorption bands of poly -OH, C=O=C, -CH2, -CH3& DPLGHS\UDQRVHULQJDQGȕ-268 
configuration of D-glucose units. As compared with the previous work by Wang et al., [36] and 269 
Liu et al., [22], the specific absorption of  G at 892.9 cm-1 GHPRQVWUDWHVWKDWWKHFRPSRXQGLVDȕ-270 
glucan. 7KHFKDUDFWHULVWLFSHDNRIWKHȕ-configuration at 892.9 cm-1 was  also noted in the spectra 271 
of  GS with two new absorption peaks at 1,170 and 867 cm-1 also present (Fig. 2), which match 272 
the to S=0 asymmetrical stretching and C-S-C symmetrical vibration [35]. These confirmed that 273 
the GS had been efficiently synthesized from G.  274 
3.2.3 NMR spectroscopy 275 
As can be seen in Fig. 3 and Fig. 4, 1H NMR spectroscopic analysis of the G and GS from 276 
G. lucidum was conducted at 80 oC using D20-d6 as a solvent. Using ppm as the standardized unit 277 
for NMR studies, 1+105VSHFWUDRIWKH*ZHUHFRPSDUHGZLWKWKHVWDQGDUGODPLQDULQȕ-1,3-D-278 
glucan) from L. digitata while the GS spectra were compared with the standard fucoidan 279 
(sulfated-ȕ-1,3-D-glucan) from F. vesiculosus. The spectrum chemical shifts of į 3.9 to 5.4 ppm 280 
and į 2.6 to 5.5 ppm exhibited indicate that both compounds were glucans, as can be observed in 281 
both Fig. 3 and Fig. 4, respectively. The current work is comparable with previous research by Ji 282 
et al., [16], which analyzed laminarin and sulfated laminarin in the area of 1H-NMR spectrum of 283 
į 4.49-5.5 ppm. Thus, these spectra indicate that the glycosidic bonds in both G (Fig. 3) and GS 284 
(Fig. 4ZHUHȕ-type. 285 
(YDOXDWLRQRIWKHµDQRPHULFUHJLRQ¶RI 1H NMR spectra in this study with those 286 
described previously specifies that they are of similar pattern [22, 33, 36]. For G (Fig. 3) 1H 287 
NMR spectra, the signals at į 5.08, 4.50 and 4.40 were assigned to OH-2, OH-6, and OH-4 when 288 
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compared with the reported work by Wagner et al., [33]. The GS (Fig. 4) 1H NMR also exhibits 289 
similarity to the G with the signals at į 5.21, 4.52 and 4.40. When compared, the anomeric 290 
signals for both compounds in the present study (G and GS) were at į 4.5 ppm and į4.2 ppm, 291 
UHVSHFWLYHO\LQGLFDWLQJȕ-configuration for glucopyranosyl units as reported by Liu et al., [22].   292 
Moreover, the 1H-NMR spectrum of the GS displayed that the chemical shift of hydrogen 293 
usually stimulated downfield relative to G, which showed that most of the hydroxyl groups in the 294 
G had been sulfated and similarly specified that GS KDGȕ-glycosidic bonds. From the IR and 1H 295 
NMR analyzed, it is possible to conclude that the G compound is composed of (1-3)-ȕ-D-296 
linkages which gave the polymer structure apparently as a1,3-ȕ-D-glucan. 297 
3.3 Assessment of antimicrobial activity  298 
 299 
The antimicrobial effect of the GS from G. lucidum was tested against ten species of 300 
bacteria as G was not evident. Their strength was measured quantitatively and qualitatively by the 301 
absence or presence of inhibition zones, zone diameters, MBC and MIC values. The findings of 302 
these tests are summarized in Table 3 (inhibition zone diameters). Among the bacterial strains 303 
tested in Table 3, when the GS reached 500 mg/mL, the diameters (mm) of the inhibition zone 304 
were 34 ± 3.2, 24 ± 2.6, 32 ± 1.0, 25 ± 2.6, 23 ± 2.8, 27 ± 1.5, 28 ± 0.5, 26 ± 1.0, 30 ± 1.0, and 30 305 
± 3.1,  for E. coli EPIC S17, E. coli, L. monocytogenes, Shigella sonnei 20071599, P. aeruginosa, 306 
S. enteritidis, Salmonella BA54 SL 1344 (pSsaG), Staph. aureus, Staph. epidermis, and 307 
Methicillin-Susceptible Staph. aureus (MSSA) ATCC 292123, respectively. The inhibition zone 308 
diameters increased with increasing GS prepared concentrations (Table 3). These reactions 309 
displayed that the antimicrobial effect of GS was dose-dependent and that the gentamicin positive 310 
control was clearly effective against all the test bacteria. 311 
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Furthermore, the MIC concentrations for bacterial strains were in the range of 1- 5 mg/mL 312 
and the MBC concentrations range was 5-10 mg/mL except the resilient Shigella sonnei 313 
20071599 (Table 3, no.3). Among four species of Gram-positive bacteria verified, the greatest 314 
active antimicrobial activity of GS was shown against Staph. aureus (Table 3, no.8), and its MIC 315 
was 2 mg/mL. Meanwhile, the antimicrobial activity of GS was verified against six species of 316 
Gram-negative microbial strains. GS exhibited fairly strongest antimicrobial activity against E. 317 
coli (Table 3, no.2) (MIC = 1 mg/mL), and seven species of microbial strains were shown to have 318 
MIC concentrations at respective 3 mg/mL while the most resistant bacterium was Staph. 319 
epidermis (Table 3, no.9) (MIC = 5 mg/mL).  320 
When compared  to other studies where derivatised fungal polymers have been examined 321 
as food preservatives and their antimicrobial activity has been assessed [8], it showed that SC2 322 
sulfated-polysaccharide (chitosan) has MIC values higher than 2 mg/mL [28] for Staph. aureus, 323 
L. monocytogenes, Vibrio parahaemolyticus, P. aeruginosa, Shigella dysenteriae, V. cholera, 324 
Aeromonas hydrophila and S. typhimurium. SC2 shows a much higher 0,&¶V against Gram-325 
positive than Gram-negative bacteria. Devlieghere [7], Muzzarelli [26] and Hernandez-Lauzardo 326 
[15] also tested the antimicrobial activity of chitosan as food preservatives and gave results for  327 
0,&¶V at or above 2.5 mg/mL. The closest comparison to the present study involved an 328 
assessment of  MIC values of an ethanolic extract of G. atrum sourced from powdered fruiting 329 
bodies varying from 1.6 to 6.25 mg/mL for the common bacterial food contaminants [20] which 330 
also reported by Ferreira et al., [11].7KXVWKH0,&¶VUHFRUGHGIRUWKH*6LQWKHSUHVHQWVWXG\DUH331 
broadly similar to those reported in other studies for fungal-derived polymers.  332 
The antimicrobial activity of some bacteria including K. pneumoniae ATCC 13883 and 333 
M. marinum ATCC BAA 535 were tested via 96-well microtitre plates to assess the antimicrobial 334 
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effects of GS. Overall, the results showed some clear inhibition of growth of both these test 335 
species (Table 4). The Gram-negative K. pneumoniae ATCC 13883 exhibited a survival of 52.8 ± 336 
5.66 % (at 500 µg/mL and 24 h incubation) while the acid-fast bacteria M. marinum ATCC BAA 337 
535 gave a survival value of 65 ± 3.39 % (at 100 µg/mL and 24 h incubation) compared to 338 
positive growth controls.  Due to the significant and increasing occurrence of nosocomial 339 
infections and destructive changes to human lungs as mentioned by Daligault et al.,[6]  by 340 
antibiotic-resistant K. pneumoniae ATCC 13883 the possibility of using novel antimicrobials 341 
from processed natural sources such as GS extracted  from G. lucidum merits further 342 
investigation and refinement. Meanwhile, GS might have some potential in controlling the 343 
occurrence of  common granulomatous  diseases arising  from M. marinum ATCC BAA 535 that 344 
affect individuals who work with fish or keep aquaria as described by Slany [31]. 345 
Overall, at present it is not entirely clear what the mechanism(s) of the antimicrobial 346 
activity of a sulfated polysaccharide such as GS is likely to be, as there are few studies in this 347 
area, meanwhile the G was negative in terms of antibacterial impact (results not shown). The 348 
steric and repulsive electrostatic properties of sulfate groups and how these might alter the spatial 349 
construction of the glucan were proposed by Ji et al., [31] as a possible contributor to the 350 
observed behavior of GS. Others suggested that changes in the flexibility of the polysaccharide 351 
backbone, and the altered water solubility could lead to variations in biotic response [3, 9, 30], 352 
which may also include the antimicrobial effects. The mechanisms of sulfation on the structure G 353 
were proposed for these positive reactions by GS. Consequently, it is essential to further studies 354 
in order investigate glucan structure-activity relationships, which might deliver a detailed 355 
foundation for their development and improvement. 356 
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Slany et al., [31] discuss the impact of sulfation on the structure and biological activity. In 357 
general, the sugar chain conformation becomes modified by the process of sulfation such that 358 
non-covalent bonds form more readily when the ±OH groups in Dȕ-glucan element are replaced 359 
with sulfate groups. Similarly, repulsions between the anionic groups lead to elongation of the 360 
sugar chain. They propose that these events result in the polymer developing an active 361 
conformation, thus initiating the bioactivity surge. 362 
In the last 20 years, there have been insufficient reports on antimicrobial activities of 363 
biopolymers from Ganoderma species [6, 14, 20, 39]. This genus has been commonly considered 364 
for its therapeutic properties, but less widely explored as a source of novel antibacterial agents 365 
[12, 14]. However, certain polysaccharides from Ganoderma species employ antibacterial 366 
activity by hindering the growth of bacteria and, in some events, by eliminating pathogenic 367 
bacteria [30]. Nearly all antibacterial investigations on Ganoderma species have been 368 
accomplished on the fruiting body and not on extracts from the liquid cultivated mycelium, a 369 
point which is made strongly in the recent review by Ferreira et al., [11]. Meanwhile, most of the 370 
positive antibacterial compounds were from alcoholic extracts, hot-water extracts and 371 
triterpenoids of fruiting bodies. The current work is the first to show positive results using GS 372 
extracted from G. lucidum mycelium produced in the bioreactor.   373 
3.4 Assessment of cytotoxicity activity 374 
 375 
The current extracted and processed GS from G. lucidum was reactive against pathogenic 376 
bacteria. Yet, to ensure whether these compounds might have clinical impact on healthy patient 377 
cells and before their introduction as new antimicrobial drugs, some preliminary assessment of 378 
the impact of such biomolecules upon normal host cells is of interest. Likewise, assessment of the 379 
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effects of such derivatized polymers on tumors is of value given the widely reported impact of 380 
other fungal macromolecules on such cell types. Accordingly, in the present study cytotoxicity 381 
assays using alamarBlue® reagent were carried out on healthy human prostate cells (PN2TA). 382 
The in vitro effects of both GS and its G from G. lucidum on PN2TA were studied in the current 383 
work (Fig. 5).  384 
In this study, a series of dose-response assays were implemented to define the cytotoxic 385 
reactions in PN2TA. Once the cells exposed to different concentrations (3, 5, 30, 50, 300 and 500 386 
µg/mL) of GS and G for 24 h, and the alamarBlue® reagent assay displayed no loss of cell 387 
viability. Morphological observations of the treated cells were the same as the control cells, 388 
therefore; these data indicated that GS and G did not exhibit cytotoxicity in PN2TA normal 389 
human cell. When compared with the previous work by Li et al., [20], the ȕ-glucan from G. 390 
atrum did not react on the viability of healthy cells, thus confirming the clinical safety of G. 391 
lucidum ȕ-glucan extracts from the current strain. 392 
The cytotoxicity of G and GS against the development of cancer cells (U937) were 393 
examined using the alamarBlue® reagent in this study. As revealed in Fig. 6, GS displayed a 394 
dose-dependent antiproliferative reactions within the value range of 10 - 60 µg/mL and exhibited 395 
stronger antiproliferation than G. GS showed the most potent antiproliferative effect at 60 µg/mL 396 
with approximately 40% antiproliferation compared to 10% for G, as the Figure shows the fewest 397 
cell growth with ascending growth towards lower concentrations. As reported, it demonstrates 398 
that the antiproliferative activity of cancer cell growth was enriched by the sulfation process (GS) 399 
as matched to the unprocessed glucan (G) [2, 35]. 400 
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The current concentration of GS (60 µg/mL) applied is considerably lower than that used 401 
in the earlier study on of sulfated glucan (sourced from Hypsizigus marmoreus) which showed 402 
only 39% of antiproliferative activity at 1000 µg/mL [2], thus further concentration increment for 403 
the current work would highly beneficial. As reported, the molecular weight, chemical 404 
configuration, degree of branching, and structure of the polymeric backbone were crucial for 405 
antiproliferative activities stimulation for both G and GS [25]. Therefore, the biochemical aspects 406 
and mechanism of the antiproliferative reactions stimulated by GS from mycelium of G. lucidum 407 
is still not fully unspoken and requests further study. 408 
In summary, it has been shown that the compounds extracted from these mycelial cultures 409 
were polysaccharide with a proposed structure RIȕ-1,3-D-glucan when compared with both 410 
standards, laminarin, and fucoidan. The antimicrobial activity of the GS from G. lucidum was 411 
effective against tested microbes in the used assays. Also, cytotoxicity of GS was evaluated with 412 
normal human prostate cells and no such effects were noted at the levels tested in this study. The 413 
GS may also have potential in antiproliferative work based on its cytotoxicity of Human-414 
Caucasian-Histiocytic-Lymphoma cancer cells (U937). These GS activities indicate that sulfate 415 
substitution on the G not only improved solubility, they also had an impact on therapeutic 416 
activities, suggesting that sulfation was an effective way to enhance these activities. In relation, 417 
the GS might have a role as a natural additive in many foods with multi-functional benefits 418 
(preservative, antiproliferative, immune-stimulation). Further examination of these functions for 419 
such polymers and their derivatives will be required.  420 
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Figures captions 427 
Fig. 1. Homogeneous reaction for sulfated (1-3)-ȕ-D-glucan (GS) preparation: process scheme. 428 
Improvised from Wang et al [36]. 429 
Fig. 2. Comparison of ȕ-glucan IR spectra. A: glucan (G); B: glucan sulfate (GS) derived from 430 
extended batch cultures of G. lucidum BCCM 31549 mycelium. 431 
 432 
Fig. 3. 1H NMR spectra of (1-3)-ȕ-D-glucan (G) derived from extended batch cultures of G. 433 
lucidum BCCM 31549 mycelium and laminarin (Laminaria digitata) standard in D20-d6 at 80 oC. 434 
Fig. 4. 1H NMR spectra of sulfated (1-3)-ȕ-D-glucan (GS) derived from extended batch cultures 435 
of G. lucidum BCCM 31549 mycelium and fucoidan (Fucus vesiculosus) standard in D20-d6 at 80 436 
oC. 437 
 438 
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Fig. 5. Cytotoxicity effects of both glucan (G) and glucan sulfate (GS) derived from extended 439 
batch cultures of G. lucidum BCCM 31549 mycelium in normal human Prostate-cell-line 440 
(PN2TA). After the cells were incubated with G and GS treatments [Control, 500, 300, 50, 30, 5, 441 
3, Triton X µg/mL], the viability was measured by alamarBlue® assay. Both G and GS had the 442 
same morphological observation under the microscope at 10x magnification. Each data was 443 
presented S.D ± mean, and the P value was > 0.05 when compared to control. If the error bars do 444 
not appear then, they are less than the size of the icon or symbol. 445 
Fig. 6. Cytotoxicity effects of glucan (G) derived from extended batch cultures of G. lucidum 446 
BCCM 31549 mycelium against cancerous human Caucasian-Histiocytic-lymphoma cell line 447 
(U937) from a 37-year-old male patient. After the cells were incubated with G treatments 448 
[Control, 60, 50, 30, 10, Triton X µg/mL], the viability was measured by alamarBlue® assay. G 449 
had morphological observation under the microscope at 10x magnification. Each data was 450 
presented S.D ± mean, and the P value was < 0.05 when compared to control. If the error bars do 451 
not appear then, they are less than the size of the icon or symbol. 452 
Fig. 7. Cytotoxicity effects of glucan sulfate (GS) derived from glucan (G) against cancerous 453 
human Caucasian-Histiocytic-lymphoma cell line (U937) from a 37-year-old male patient. After 454 
the cells were incubated with GS treatments [Control, 60, 50, 30, 10, Triton X µg/mL], the 455 
viability was measured by alamarBlue® assay. GS had morphological observation under the 456 
microscope at 10x magnification. Each data was presented S.D ± mean, and the P value was < 457 
0.05 when compared to control. If the error bars do not appear then, they are less than the size of 458 
the icon or symbol. 459 
 460 
 461 
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Tables 
Table 1 
Solubility properties of glucan sulfate (GS) prepared from glucan (G) derived from extended 
batch cultures of G. lucidum BCCM 31549 mycelium 
Characteristics G GS 
Appearance White powder Reddish brown slime 
Dry weight (g) 1.6 1.4 
Yield (%) - 87.5 
Water solubility (%) (w/v) Below 5 Above 95 
*Values are means of four batches 
Table 2 
Elemental analysis of glucan (G) and glucan sulfate (GS) derived from extended batch cultures of 
G. lucidum BCCM 31549 mycelium 
 
Sample 
 
C 
 
H 
(w/w) % 
N 
 
O 
 
S 
 
 (DS) 
 
G 
 
28.60 ±1.2 
 
3.28 ±1.2 
 
1.79 ±0.5 
 
65.08 ±1.3 
 
1.25 ±0.5 
 
- 
Laminarin  39.36 ±2.2 6.47 ±1.5 0.32 ±0.01 52.84 ±1.8 1.01 ±0.2 - 
       
GS 24.50 ±2.1 5.72 ±1.6 10.01 ±0.9 49.92 ±1.3 9.85 ±1.1 0.90 
Fucoidan  24.10 ±1.9 4.24 ±1.4 0.3 ±0.01 64.49 ±2.1 6.87 ±1.3 0.64 
* Laminarin is a standard for (1,3)-ȕ-D-glucan from  Laminaria digitata 
* Fucoidan  is a standard for sulfated-(1,3)-ȕ-D-glucan from  Fucos vesiculosus 
* Values were in triplicate and presented in mean ± S.D. P value is <0.05. 
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Table 3  
Antimicrobial activities of glucan sulfate (GS) derived from extended batch cultures of G. lucidum BCCM 31549 mycelium a 
 
 
No./ 
G 
 
 
Bacteria 
GS    
 
GENT c 
30 µg 
 
 
 
Ethanol c 
100% 
Diameter of inhibition zone b (mm)  
MIC d 
mg/mL 
 
MBC e 
mg/mL 200 
mg/mL 
300 
mg/mL 
400 
mg/mL 
500 
mg/mL 
1 (G-) Escherichia coli EPIC S17 
 
22 ± 2.6 26 ± 1.2 29 ± 1.0 34 ± 3.2 3 10 19 ± 2.5 11.4 ± 0.1 
2 (G-) Escherichia coli 
 
20 ± 1.5 22 ± 1.5 20 ± 1.1 24 ± 2.6 1 2 23 ± 3.1 11.3 ± 0.1 
3 (G-) Shigella sonnei 20071599 
 
16 ± 1.0 21 ± 0.5 23 ± 2.1 25 ± 2.6 3 20 22 ± 1.5 11.4 ± 0.1 
4 (G-) Pseudomonas aeruginosa 
 
16 ± 1.0 20 ± 1.0 20 ± 0.5 23 ± 2.8 3 5 23 ± 1.1 11.2 ± 0.1 
5 (G-) Salmonella enteritidis 
 
17 ± 1.5 20 ± 1.0 23 ± 1.0 27 ± 1.5 3 10 24 ± 2.5 11.1 ± 0.1 
6 (G-) Salmonella BA54SL1344 (pSsaG) 
 
20 ± 2.1 24 ± 1.5 26 ± 1.0 28 ± 0.5 3 5 28 ± 2.0 11.2 ± 0.1 
7 (G+) Listeria monocytogenes 
 
26 ± 2.1 28 ± 1.0 30 ± 1.5 32 ± 1.0 3 8 34 ± 1.0 11.1 ± 0.1 
8 (G+) Staphylococcus aureus 
 
18 ± 1.0 20 ± 0.5 21 ± 2.3 26 ± 1.0 2 5 21 ± 1.0 11.1 ± 0.1 
9 (G+) Staphylococcus epidermis 22 ± 1.5 23 ± 4.0 28 ± 1.5 30 ± 1.0 5 10 27 ± 1.5 11.2 ± 0.1 
 
10 (G+) Methicillin-Susceptible-
Staphylococcus aureus ATCC 
292123 ATCC 292123 
22 ± 2.1 24 ± 2.0 27 ± 1.2 30 ± 3.1 3 10 25 ± 2.5 11.2 ± 0.1 
a Values represent mean ± S.D (P < 0.05) for triplicate experiments. G indicates Gram positive (G+) or Gram negative (G-) bacteria 
b
 Sterile disc size was 11 mm indicating negative reactions and positive reactions were more than 11 mm. 
c
 Ethanol was used as the negative control while Gentamicin (GENT) was used as the positive control.  
d
 The minimum inhibiting concentration (MIC) (as mg/mL). e The minimum bactericidal concentration (MBC) (as mg/mL)  
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Table 4 
Activity of glucan sulfate (GS) derived from extended batch cultures of G. lucidum BCCM 
31549 mycelium using 96-well microtitre plates a 
 
 
Bacteria 
 
Klebsiella 
pneumoniae ATCC 
13883 
 
Mycobacterium 
marinum ATCC. 
BAA. 535 
 
 
 
Gentamicin 
 
 
 
DMSO 
 
Gram 
 
(-) 
 
Acid-fast bacteria 
 
GS 
(µg/mL) 
 
 
500 
 
100 
 
100 
 
100 
Survival ratio b 
(% of control) 
 
52.8 ± 5.66 65 ± 3.39 1 ± 1.20 99 ± 1.05 
Inhibition status Positive Positive (+) control (-) control 
a Values represent averages ± S.D (P < 0.05) for triplicate experiments 
b Lower percentage of control value means the greater antibacterial effect 
 
 
 
 
 
 
 
 
 32 
 
References 
 
1. Alvarez-Suarez JM, Tulipani S, Díaz D, Estevez Y, Romandini S, Giampieri F, et al. 
2010. Antioxidant and antimicrobial capacity of several monofloral Cuban honeys and 
their correlation with color, polyphenol content and other chemical compounds. Food 
Chem Toxicol. 48: 2490-2499. 
2. Bao H, Choi W-S, and You S. 2010. Effect of sulfated modification on the molecular 
characteristics and biological activities of polysaccharides from Hypsizigus marmoreus. 
Biosci Biotech Biochem. 74: 1408-1414. 
3. Bao XF, Wang XS, Dong Q, Fang JN, and Li XY. 2002. Structural features of 
immunologically active polysaccharides from Ganoderma lucidum. Phytochem. 59: 175-
181. 
4. Cechinel-Filho V. 2012. Plant bioactives and drug discovery: principles, practice, and 
perspectives. John Wiley & Sons, Inc., Hoboken, New Jersey. 
5. Chen S, Wang J, Xue C, Li H, Sun B, Xue Y, and Chai W. 2010. Sulfation of a squid ink 
polysaccharide and its inhibitory effect on tumor cell metastasis. Carbohydr Polym. 81: 
560-566. 
6. Daligault H, Davenport K, Minogue T, Bishop-Lilly K, Bruce D, Chain P, et al. 2014. 
Draft genome assembly of Klebsiella pneumoniae type strain ATCC 13883. Genome 
Announc. 2: e00939-00914. 
7. Devlieghere F, Vermeulen A, and Debevere J. 2004. Chitosan: antimicrobial activity, 
interactions with food components and applicability as a coating on fruit and vegetables. 
Food Microbiol. 21: 703-714. 
8. Dutta P, Tripathi S, Mehrotra G, and Dutta J. 2009. Perspectives for chitosan based 
antimicrobial films in food applications. Food Chem. 114: 1173-1182. 
9. Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, et al. 
2010. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus 
causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemoth. 65: 446-
448. 
10. Fazenda ML, Harvey LM, and McNeil B. 2010. Effects of dissolved oxygen on fungal 
morphology and process rheology during fed-batch processing of Ganoderma lucidum. J 
Microbiol Biotechnol. 20: 844-851. 
11. Ferreira IC, Heleno SA, Reis FS, Stojkovic D, Queiroz MJR, Vasconcelos MH, and 
Sokovic M. 2015. Chemical features of Ganoderma polysaccharides with antioxidant, 
antitumor and antimicrobial activities. Phytochem. 114: 38-35. 
 33 
 
12. Gao Y, Zhou S, Huang M, and Xu A. 2003. Antibacterial and antiviral value of the genus 
Ganoderma P. Karst. species (aphyllophoromycet-ideae): a review. Int J Med Mushrooms. 
5: 235±246. 
13. Han MD, Han YS, Hyun SH, and Shin HW. 2008. Solubilization of water-LQVROXEOHȕ-
glucan isolated from Ganoderma lucidum. J Environ Biology. 29: 237-242. 
14. +HOHQR6$)HUUHLUD,&(VWHYHV$3ûLULü$*ODPRþOLMD-0DUWLQV$, et al. 2013. 
Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-
hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl 
esters. Food Chem Toxicol. 58: 95-100. 
15. Hernández-Lauzardo A, Bautista-Baños S, Velázquez-del Valle M, Méndez-Montealvo 
M, Sánchez-Rivera M, and Bello-Pérez L. 2008. Antifungal effects of chitosan with 
different molecular weights on in vitro development of Rhizopus stolonifer (Ehrenb.: Fr.) 
Vuill. Carbohydr Polym. 73: 541-547. 
16. Ji CF, Ji YB, and Meng DY. 2013. Sulfated modification and anti-tumor activity of 
laminarin. Exp Ther Med. 6: 1259-1264. 
17. Karnjanapratum S, Tabarsa M, Cho M, and You S. 2012. Characterization and 
immunomodulatory activities of sulfated polysaccharides from Capsosiphon fulvescens. 
Int J Biol Macromol. 51: 720-729. 
18. Khalaf AI, Bourdin C, Breen D, Donoghue G, Scott FJ, Suckling CJ, et al. 2012. Design, 
synthesis and antibacterial activity of minor groove binders: the role of non-cationic tail 
groups. Eur J Med Chem. 56: 39-47. 
19. Kimura Y, Taniguchi M, and Baba K. 2002. Antitumor and antimetastatic effects on liver 
of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an 
active substance. Anticancer research. 22: 3309±3318. 
20. Li WJ, Nie SP, Liu XZ, Zhang H, Yang Y, Yu Q, and Xie MY. 2012. Antimicrobial 
properties, antioxidant activity and cytotoxicity of ethanol-soluble acidic components 
from Ganoderma atrum. Food Chem Toxicol. 50: 689-694. 
21. Liao SF, Liang CH, Ho MY, Hsu TL, Tsai TI, Hsieh YS, et al. 2013. Immunization of 
fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-
associated Globo H-series epitopes. Proc Natl Acad Sci USA. 110: 13809-13814. 
22. Liu Y, Zhang J, Tang Q, Yang Y, Guo Q, Wang Q, et al. 2014. Physicochemical 
characterization of a high molecular weight bioactive beta-D-glucan from the fruiting 
bodies of Ganoderma lucidum. Carbohydr Polym. 101: 968-974. 
23. Liu YJ, Shen J, Xia YM, Zhang J, and Park HS. 2012. The polysaccharides from 
Ganoderma lucidum: Are they always inhibitors on human hepatocarcinoma cells? 
Carbohydr Polym. 90: 1210-1215. 
 34 
 
24. Llaurado G, Morris HJ, Ferrera L, Camacho M, Castan L, Lebeque Y, et al. 2015. In-vitro 
antimicrobial activity and complement/macrophage stimulating effects of a hot-water 
extract from mycelium of the oyster mushroom Pleurotus sp. Innov Food Sci Emerg. 30: 
177-183. 
25. Ma CW, Feng MY, Zhai XF, Hu MH, You LJ, Luo W, and Zhao MM. 2013. 
Optimization for the extraction of polysaccharides from Ganoderma lucidum and their 
antioxidant and antiproliferative activities. J Taiwan Inst Chem E. 44: 886-894. 
26. Muzzarelli R, Tarsi R, Filippini O, Giovanetti E, Biagini G, and Varaldo P. 1990. 
Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob Agents Ch. 34: 2019-
2023. 
27. Peng Y, Zhang L, Zhang Y, Xu X, and Kennedy JF. 2005. Solution properties of water-
insoluble polysaccharides from the mycelium of Ganoderma tsugae. Carbohydr Polym. 
59: 351-356. 
28. Shahidi F, Arachchi JKV, and Jeon Y-J. 1999. Food applications of chitin and chitosans. 
Trends Food Sci Tech. 10: 37-51. 
29. Shi M, Zhang Z, and Yang Y. 2013. Antioxidant and immunoregulatory activity of 
Ganoderma lucidum polysaccharide (GLP). Carbohydr Polym. 95: 200-206. 
30. Skalicka-Wozniak K, Szypowski J, Los R, Siwulski M, Sobieralski K, Glowniak K, and 
Malm A. 2012. Evaluation of polysaccharides content in fruit bodies and their 
antimicrobial activity of four Ganoderma lucidum (W Curt. Fr.) P. Karst. strains 
cultivated on different wood type substrates. Acta Soc Bot Pol. 81: 17-21. 
31. Slany M, Jezek P, Fiserova V, Bodnarova M, Stork J, Havelkova M, et al. 2011. 
Mycobacterium marinum infections in humans and tracing of its possible environmental 
sources. Canadian J Microbiol. 58: 39-44. 
32. Suzuki T, Ohno N, Adachi Y, Cirelli AF, Covian JA, and Yadomae T. 1991. Preparation 
and biological activities of sulfated derivatives of (1-3)-beta-D-glucans. J 
Pharmacobiodyn. 14: 256-266. 
33. Wagner R, Mitchell DA, Sassaki GL, Amazonas MALD, and Berovic M. 2003. Current 
techniques for the cultivation of Ganoderma lucidum for the production of biomass, 
ganoderic acid and polysaccharides. Food Technol Biotech. 41: 371-382. 
34. Wang J and Zhang L. 2009. Structure and chain conformation of five water-soluble 
GHULYDWLYHVRIDȕ-d-glucan isolated from Ganoderma lucidum. Carbohyd Res. 344: 105-
112. 
35. Wang J, Zhang L, Yu Y, and Cheung PC. 2009. Enhancement of antitumor activities in 
sulfated and carboxymethylated polysaccharides of Ganoderma lucidum. J Agr Food 
Chem. 57: 10565-10572. 
 35 
 
36. Wang Y-J, Yao S-J, Guan Y-X, Wu T-X, and Kennedy J. 2005. A novel process for 
SUHSDUDWLRQRIĺ-ȕ-D-glucan sulphate by a heterogeneous reaction and its structural 
elucidation. Carbohydr Polym. 59: 93-99. 
37. Williams DL, Pretus HA, McNamee RB, Jones EL, Ensley HE, and Browder IW. 1992. 
Development of a water-soluble, sulfated (1-->3)-beta-D-glucan biological response 
modifier derived from Saccharomyces cerevisiae. Carbohydr Res. 235: 247-257. 
38. Xu Z, Chen X, Zhong Z, Chen L, and Wang Y. 2011. Ganoderma lucidum 
polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 
39: 15-27. 
39. Yoon SY, Eo SK, Kim YS, Lee CK, and Han SS. 1994. Antimicrobial activity of 
Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm 
Res. 17: 438-442. 
40. Zhang J, Liu Y-j, Park H-s, Xia Y-m, and Kim G-s. 2012. Antitumor activity of sulfated 
extracellular polysaccharides of Ganoderma lucidum from the submerged fermentation 
broth. Carbohydr Polym. 87: 1539-1544. 
 
